Not applicableUnknownNCT06194565What this trial is testing99mTc-ABH2 SPECT/CT in Breast CancerWho this might be right forBreast Cancer Peking Union Medical College Hospital 40
Large-scale testing (Phase 3)Looking for participantsNCT06340568What this trial is testingA Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine CancerWho this might be right forEndometrial Cancer BioNTech SE 480
Testing effectiveness (Phase 2)Looking for participantsNCT06420973What this trial is testingRC48 Treatment for Platinum Sensitive Recurrent Ovarian Cancer With HER2 ExpressionWho this might be right forOvarian CarcinomaFallopian Tube CarcinomaPrimary Peritoneal Carcinoma Peking University Cancer Hospital & Institute 54
Not applicableStudy completedNCT02954471What this trial is testingStudy of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Participants With Early/Metastatic Breast Cancer in Saudi ArabiaWho this might be right forBreast Cancer Hoffmann-La Roche 351
Testing effectiveness (Phase 2)Active Not RecruitingNCT05824325What this trial is testingDifferent Targeted Antibody-drug Conjugates For HER2 Ultra-low or No Expression Advanced Breast Cancer（GALAXY）Who this might be right forBreast Cancer Fudan University 56
Not applicableUnknownNCT02852096What this trial is testingAssessing Her2/Neu Expression in Gastric Cancer With Dual or Multiple Tumor Tissue Paraffin BlocksWho this might be right forGastric CancerHER-2 Shanghai Zhongshan Hospital 600
Not applicableLooking for participantsNCT04281641What this trial is testingMarkers to Evaluate the Efficacy of PH-based Regimen as a Neoadjuvant Therapy for Operable HER2 Positive Breast CancerWho this might be right forHER2-positive Breast Cancer Fudan University 94
Testing effectiveness (Phase 2)Study completedNCT00107393What this trial is testingTrastuzumab and Capecitabine in Treating Women With Metastatic Breast CancerWho this might be right forBreast Cancer Tohoku University 75
Testing effectiveness (Phase 2)Looking for participantsNCT06123338What this trial is testingPembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric CancerWho this might be right forEsophageal CancerGastric AdenocarcinomaHER2 Gene Mutation Memorial Sloan Kettering Cancer Center 49
Not applicableLooking for participantsNCT06909604What this trial is testingAl18F-HER2-BCH PET in Breast Patients Treated With ADC TherapyWho this might be right forBreast Cancer Peking University Cancer Hospital & Institute 50
Testing effectiveness (Phase 2)Looking for participantsNCT05769010What this trial is testingStudy of SHR-A1811 in HER2-expression Advanced Breast Cancer With Brain MetastasesWho this might be right forMetastatic Breast Cancer Henan Cancer Hospital 150
Testing effectiveness (Phase 2)Study completedNCT03052634What this trial is testingRC48-ADC in Subjects With Advanced Breast CancerWho this might be right forAdvanced Breast Cancer RemeGen Co., Ltd. 112
Testing effectiveness (Phase 2)Looking for participantsNCT06439771What this trial is testingEvaluate the Efficacy, Safety and Pharmacokinetics of YL202 in Patients With BCWho this might be right forLocally Advanced or Metastatic Breast Cancer MediLink Therapeutics (Suzhou) Co., Ltd. 180
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07757230What this trial is testingA Phase II Study of SSGJ-612 Plus a HER2-Targeted ADC in HR-Positive, HER2-Low or HER2-Ultralow Expression Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Shenyang Sunshine Pharmaceutical Co., LTD. 87
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07047443What this trial is testingSHR-1811 Combined With Carboplatin in the Treatment of Advanced Breast Cancer With HER2 ExpressionWho this might be right forBreast Cancer Anhui Provincial Cancer Hospital 18
Not applicableUnknownNCT03655353What this trial is testing68Ga-ABY-025 PET for Non-invasive Quantification of HER2-expression in Advanced Breast CancerWho this might be right forHER2-positive Breast Cancer Henrik Lindman 160
Not applicableUnknownNCT05169853What this trial is testingProgrammed Death-Ligand1 Expression in Her-2 Positive and Triple Negative Breast CancerWho this might be right forTriple Negative Breast CancerHER2-positive Breast Cancer Ain Shams University 80
Early research (Phase 1)Active Not RecruitingNCT04704661What this trial is testingTesting the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH TrialWho this might be right forAdvanced Breast CarcinomaAdvanced Colon CarcinomaAdvanced Colorectal Carcinoma+37 more National Cancer Institute (NCI) 51
Not applicableStudy completedNCT00896727What this trial is testingS9313A Protein Expression Analysis of Breast Cancer Tissue Microarrays From Clinical Trial SWOG-9313Who this might be right forBreast Cancer SWOG Cancer Research Network 2,100
Testing effectiveness (Phase 2)Ended earlyNCT00636441What this trial is testingTrial to Evaluate Genomic Expression Profiles to Direct Preoperative Chemotherapy in Early Stage Breast CancerWho this might be right forEarly-Stage Breast Cancer Duke University 56